High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs.
作者信息
Bromfield Samantha, Muntner Paul
机构信息
University of Alabama at Birmingham, Birmingham, AL 35294, USA.
出版信息
Curr Hypertens Rep. 2013 Jun;15(3):134-6. doi: 10.1007/s11906-013-0340-9.
Abstract
摘要
相似文献
1
High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs.高血压：全球主要的疾病风险因素负担以及全球预防计划的必要性。
Curr Hypertens Rep. 2013 Jun;15(3):134-6. doi: 10.1007/s11906-013-0340-9.
2
The global burden of hypertension: good news and bad news.高血压的全球负担：好消息与坏消息。
Cardiol Clin. 2002 May;20(2):181-5, v. doi: 10.1016/s0733-8651(02)00002-4.
3
Recommendations for global hypertension monitoring and prevention.全球高血压监测和预防建议。
Curr Hypertens Rep. 2009 Dec;11(6):444-9. doi: 10.1007/s11906-009-0075-9.
4
State of global health--hypertension burden and control.全球健康状况——高血压负担与控制
Blood Press. 2012 Jul;21 Suppl 1:1-2. doi: 10.3109/08037051.2012.704786.
5
Using the Global Burden of Disease study to assist development of nation-specific fact sheets to promote prevention and control of hypertension and reduction in dietary salt: a resource from the World Hypertension League.利用全球疾病负担研究协助制定各国情况说明书，以促进高血压的预防和控制并减少膳食盐摄入：世界高血压联盟提供的一份资源。
J Clin Hypertens (Greenwich). 2015 Mar;17(3):165-7. doi: 10.1111/jch.12479. Epub 2015 Jan 31.
6
The value of risk assessment and burden of disease analyses.风险评估与疾病负担分析的价值。
J Hypertens. 2006 Apr;24(4):783-4. doi: 10.1097/01.hjh.0000217863.50735.95.
7
Challenges for the management of hypertension in low-resource settings.资源匮乏地区高血压管理面临的挑战。
Ethn Dis. 2003 Summer;13(2 Suppl 2):S67-70.
8
Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.评估中国心血管疾病的未来负担以及血脂和血压控制疗法的价值。
BMC Health Serv Res. 2016 May 10;16:175. doi: 10.1186/s12913-016-1420-8.
9
High blood pressure selected as the theme for World Health Day, April 7, 2013: cup half full or half empty?2013年4月7日世界卫生日选定高血压为主题：是福还是祸？
Can J Cardiol. 2013 Apr;29(4):415-7. doi: 10.1016/j.cjca.2013.01.014. Epub 2013 Feb 28.
10
Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the "Global Burden of Disease 2017" (GBD 2017) study.1990 年至 2017 年巴西与收缩压高相关的流行率、死亡率和发病率趋势：来自“全球疾病负担 2017”（GBD 2017）研究的估计。
Popul Health Metr. 2020 Sep 30;18(Suppl 1):17. doi: 10.1186/s12963-020-00218-z.
引用本文的文献
1
Awareness of hypertension-related complications and its determinants among adult hypertensive patients in Ethiopia.埃塞俄比亚成年高血压患者对高血压相关并发症及其决定因素的认知情况。
Front Cardiovasc Med. 2025 Aug 29;12:1563249. doi: 10.3389/fcvm.2025.1563249. eCollection 2025.
2
The impact of marital status on hypertension: SEM analysis of a Chinese general population cohort.婚姻状况对高血压的影响：中国普通人群队列的结构方程模型分析
BMC Public Health. 2025 Aug 30;25(1):2981. doi: 10.1186/s12889-025-24382-9.
3
Constructing a T-Test for Value Function Comparison of Individualized Treatment Regimes in the Presence of Multiple Imputation for Missing Data.在存在缺失数据多重填补的情况下构建用于个性化治疗方案价值函数比较的t检验。
Stat Med. 2025 Aug;44(18-19):e70210. doi: 10.1002/sim.70210.
4
Socioeconomic inequality for hypertension among reproductive age women aged 15-49 from five Sub-Saharan Africa countries: A decomposition analysis of DHS Data.撒哈拉以南非洲五个国家15至49岁育龄妇女高血压的社会经济不平等：基于人口与健康调查（DHS）数据的分解分析
PLOS Glob Public Health. 2025 Jul 2;5(7):e0004738. doi: 10.1371/journal.pgph.0004738. eCollection 2025.
5
Microphysiological Uremia Model Reveals Biophysical Potentiators of Vascular Dysfunction.微生理尿毒症模型揭示血管功能障碍的生物物理增强剂。
Adv Sci (Weinh). 2025 Sep;12(33):e17091. doi: 10.1002/advs.202417091. Epub 2025 Jun 20.
6
Trends in Hypertension Diagnosis and Self-Reported Cases: A Retrospective Analysis of National Health Interview Survey (NHIS) Database.高血压诊断及自我报告病例的趋势：基于国家健康访谈调查（NHIS）数据库的回顾性分析
Cureus. 2025 Mar 16;17(3):e80655. doi: 10.7759/cureus.80655. eCollection 2025 Mar.
7
Mortality trends of renal diseases due to hypertension in adults: an analysis of gender, race, place of death, and geographical disparities in the United States from 1999 to 2020.成人高血压所致肾脏疾病的死亡率趋势：对1999年至2020年美国的性别、种族、死亡地点及地理差异的分析
Int Urol Nephrol. 2025 Apr 4. doi: 10.1007/s11255-025-04493-3.
8
Factors associated to hypertension knowledge and control in Kimpese, Democratic Republic of the Congo.刚果民主共和国金佩塞地区与高血压知识及控制相关的因素
Afr J Prim Health Care Fam Med. 2025 Mar 31;17(1):e1-e7. doi: 10.4102/phcfm.v17i1.4721.
9
Impact of value-based care on quality of life, clinical outcomes, patient satisfaction, and enhanced financial protection among hypertensive patients in Ghana: A protocol for a mixed method evaluation, 2024.基于价值的医疗保健对加纳高血压患者生活质量、临床结局、患者满意度及增强财务保护的影响：一项混合方法评估方案，2024年
PLoS One. 2025 Apr 1;20(4):e0320861. doi: 10.1371/journal.pone.0320861. eCollection 2025.
10
Effect of amphetamines on blood pressure.安非他命对血压的影响。
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD007896. doi: 10.1002/14651858.CD007896.pub4.
本文引用的文献
1
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.21 个地区 1990-2010 年 67 种致病因素和致病因素群导致的疾病和伤害负担的比较风险评估：全球疾病负担研究 2010 系统分析。
Lancet. 2012 Dec 15;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8.
2
National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.1980 年以来全球、地区和国家的收缩压趋势：对 786 个国家年和 540 万人的健康检查调查和流行病学研究的系统分析。
Lancet. 2011 Feb 12;377(9765):568-77. doi: 10.1016/S0140-6736(10)62036-3. Epub 2011 Feb 3.
3
The burden of blood pressure-related disease: a neglected priority for global health.血压相关疾病的负担：全球健康中一个被忽视的重点。
Hypertension. 2007 Dec;50(6):991-7. doi: 10.1161/HYPERTENSIONAHA.107.095497. Epub 2007 Oct 22.
4
Global burden of hypertension: analysis of worldwide data.高血压的全球负担：全球数据分析
Lancet. 2005;365(9455):217-23. doi: 10.1016/S0140-6736(05)17741-1.
5
The natural history of hypertension.高血压的自然病史。
Br Med Bull. 1952;8(4):305-9. doi: 10.1093/oxfordjournals.bmb.a074193.
6
Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention.亚洲的高血压与中风：发展中国家的患病率、控制情况及预防策略
J Hum Hypertens. 2000 Oct-Nov;14(10-11):749-63. doi: 10.1038/sj.jhh.1001057.
7
Hypertension and cardiovascular health in Venezuela and Latin American countries.委内瑞拉及拉丁美洲国家的高血压与心血管健康
J Hum Hypertens. 2000 Apr;14 Suppl 1:S2-5. doi: 10.1038/sj.jhh.1000978.
8
Hypertension in India--definition, prevalence and evaluation.印度的高血压——定义、患病率及评估
J Indian Med Assoc. 1999 Mar;97(3):74-80.
9
Cardiovascular disease in developing countries: myths, realities, and opportunities.发展中国家的心血管疾病：误区、现状与机遇
Cardiovasc Drugs Ther. 1999 Apr;13(2):95-104. doi: 10.1023/a:1007727924276.
10
Mortality by cause for eight regions of the world: Global Burden of Disease Study.世界八个地区按病因划分的死亡率：全球疾病负担研究
Lancet. 1997 May 3;349(9061):1269-76. doi: 10.1016/S0140-6736(96)07493-4.
Zotero 插件